Minoryx Therapeutics SL
Latest round
- Series C
Last raised
- Apr 2022
Total raised
- $94M
Investors
- 15
About Minoryx Therapeutics SL
Based in Barcelona, Spain, and founded in 2011, Minoryx Therapeutics SL operates as a biotechnology company that develops small-molecule drugs. The company was founded by its CEO, Marc Martinell, Xavier Barril, and Joan Aymamí. Minoryx Therapeutics develops novel therapies for diseases affecting the CNS, including X-linked adrenoleukodystrophy (X-ALD) and Friedreich's ataxia (FRDA). The company's pipeline project includes a marketing authorization application (MAA) for the development of leriglitazone (MIN-102), a PPAR gamma agonist. This drug candidate has been developed for the treatment of adult male X-ALD patients with AMN, a neurodegenerative disease that exists in two forms: a chronic form, AMN, and an acute form, cerebral ALD (cALD).
Who invested in Minoryx Therapeutics SL
15 investors across 5 rounds
See all investors in Minoryx Therapeutics SL
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Minoryx Therapeutics SL
Who invested in Minoryx Therapeutics SL?
Minoryx Therapeutics SL has 15 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Minoryx Therapeutics SL raised?
Minoryx Therapeutics SL has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Minoryx Therapeutics SL last raise money?
Minoryx Therapeutics SL's most recent round on record is a Series C, in Apr 2022.
What does Minoryx Therapeutics SL do?
Based in Barcelona, Spain, and founded in 2011, Minoryx Therapeutics SL operates as a biotechnology company that develops small-molecule drugs.
Where is Minoryx Therapeutics SL headquartered?
Minoryx Therapeutics SL is headquartered in Barcelona, Spain.
Which VCs invest in companies like Minoryx Therapeutics SL?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Minoryx Therapeutics SL's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Minoryx Therapeutics SL? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.